Fish oil has been promised to provide all sorts of health benefits – from boosting our heart health, protecting our brain and easing arthritis. Here’s how the claims stack up for fish and supplements.
Rigor académico, oficio periodístico
Artículos sobre Alzheimer's disease
Mostrando 1 - 20 de 317 artículos
These blood tests results need care when interpreting, and they can not they predict how the disease will affect each person.
Despite decades of starts and stops, new treatments and key genetic discoveries are giving researchers great hope for slowing or eventually preventing Alzheimer’s disease.
Several new drugs have recently been approved in the US to treat Alzheimer’s disease. But they’re not quite the breakthrough that some are claiming.
Disorders such as Alzheimer’s and epilepsy are difficult to diagnose with only occasional doctor visits. A new approach would allow fathering of extensive real-world data directly from patients.
Humans have attempted to understand and treat mental illness for centuries – from ancient Greek medicine, Middle Ages exorcisms and the rise of asylums, to modern medical breakthroughs.
While there is no guarantee of warding off cognitive decline, encouraging people to be physically, mentally and socially active could potentially keep a significant number of dementia cases at bay.
In the short-term, inflammation is a sign your body is healing. But persistent levels of inflammation in blood and tissue, called ‘inflammaging’, is linked to disease. Diet might help.
The drug has been hailed as a ‘turning point’ in Alzheimer’s treatment. But keep in mind the trial only included participants with early or mild disease. And while it slowed decline, it’s not a cure.
Around one in 20 people with Alzheimer’s disease are diagnosed before the age of 65.
People living with dementia often become more confused in the late afternoon and into the night. Why, and what can we do about it?
Alzheimer’s disease is the most prevalent form of dementia. This is a term used to describe a range of symptoms linked to the decline in brain function with age.
A machine learning algorithm was able to accurately predict those with preclinical Alzheimer’s disease based on their gut microbe composition.
The surprising parallel between spider silk spinning and fibres toxic to humans could lead to new clues about how to fight neurodegenerative disorders.
People with Down syndrome have an extra chromosome 21. Understanding the effects of those triplicated genes could help improve the health of those with Down syndrome and other medical conditions.
REM sleep behavior disorder is characterized by acting out dreams, which may include shouting, kicking and punching during sleep.
Judges called it a profound novel that asks the contemporary question: what happens to us when our memories disappear?
The much-discussed weight-loss jab may be good for treating Britain’s biggest killer: dementia. Trials are underway.
Late-stage trial results suggest the drug can slow cognitive decline by 35%.
But it could still save you from dementia.
Principales colaboradores
-
Research Fellow in Neuroimmunology, UCL
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Professor of Neurology and Neuroscience, University of Florida
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Post grad student at University of Edinburgh, The University of Edinburgh
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Professor of Neurology, UCL
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Associate Professor, Monash University
-
Professor of Psychology in Epidemiology, UCL
-
Professor in Ageing and Health, University of Sydney
-
Professor and Head of Epigenetics and Neural Plasticity, Florey Institute of Neuroscience and Mental Health
-
Associate Professor of Medicine and Geriatrics, University of Virginia
-
Associate professor, University of Sydney
-
Director, Evelyn F. and William L. McKnight Brain Institute Director, 1Florida Alzheimer’s Disease Research Center, Professor, Department of Neuroscience, College of Medicine University of Florida, University of Florida
